Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexey Koval

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
The Biochemical Journal|December 7, 2010
Wnt3a stimulation elicits G-protein-coupled receptor properties of mammalian Frizzled proteinsAlexey Koval, Vladimir L Katanaev
Drug Discovery Today|July 24, 2012
Platforms for high-throughput screening of Wnt/Frizzled antagonistsAlexey Koval, Vladimir L Katanaev
Scientific Reports|May 11, 2018
Dramatic dysbalancing of the Wnt pathway in breast cancersAlexey Koval, Vladimir L Katanaev
Frontiers in Oncology|December 28, 2020
Beyond TNBC: Repositioning of Clofazimine Against a Broad Range of Wnt-Dependent CancersJiabin Xu, Alexey Koval, Vladimir L Katanaev
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 24, 2023
Clofazimine: A journey of a drugJiabin Xu, Alexey Koval, Vladimir L Katanaev
Iscience|July 28, 2023
Improved approaches to channel capacity estimation discover compromised GPCR signaling in diverse cancer cellsAlexey Koval, Xin Zhang, Vladimir L Katanaev
The Biochemical Journal|November 26, 2015
Inhibition of Wnt signalling and breast tumour growth by the multi-purpose drug suramin through suppression of heterotrimeric G proteins and Wnt endocytosisAlexey Koval, Kamal Ahmed, Vladimir L Katanaev
Science Signaling|August 26, 2010
A direct and functional interaction between Go and Rab5 during G protein-coupled receptor signalingVladimir Purvanov, Alexey Koval, Vladimir L Katanaev
ACS Pharmacology & Translational Science|December 19, 2024
Challenging Reported Frizzled-Targeting Compounds in Selective Assays Reveals Lack of Functional Inhibition and Claimed ProfilesAlexey Koval, Cédric Boudou, Vladimir L Katanaev
Bioscience Reports|April 23, 2026
Small-molecule inhibitor of Gαo for GNAO1 encephalopathyYonika A Larasati, Alexey Koval, Vladimir L Katanaev
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
The Biochemical Journal|December 7, 2010
Wnt3a stimulation elicits G-protein-coupled receptor properties of mammalian Frizzled proteinsAlexey Koval, Vladimir L Katanaev
Drug Discovery Today|July 24, 2012
Platforms for high-throughput screening of Wnt/Frizzled antagonistsAlexey Koval, Vladimir L Katanaev
Scientific Reports|May 11, 2018
Dramatic dysbalancing of the Wnt pathway in breast cancersAlexey Koval, Vladimir L Katanaev
Frontiers in Oncology|December 28, 2020
Beyond TNBC: Repositioning of Clofazimine Against a Broad Range of Wnt-Dependent CancersJiabin Xu, Alexey Koval, Vladimir L Katanaev
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 24, 2023
Clofazimine: A journey of a drugJiabin Xu, Alexey Koval, Vladimir L Katanaev
Iscience|July 28, 2023
Improved approaches to channel capacity estimation discover compromised GPCR signaling in diverse cancer cellsAlexey Koval, Xin Zhang, Vladimir L Katanaev
The Biochemical Journal|November 26, 2015
Inhibition of Wnt signalling and breast tumour growth by the multi-purpose drug suramin through suppression of heterotrimeric G proteins and Wnt endocytosisAlexey Koval, Kamal Ahmed, Vladimir L Katanaev
Science Signaling|August 26, 2010
A direct and functional interaction between Go and Rab5 during G protein-coupled receptor signalingVladimir Purvanov, Alexey Koval, Vladimir L Katanaev
ACS Pharmacology & Translational Science|December 19, 2024
Challenging Reported Frizzled-Targeting Compounds in Selective Assays Reveals Lack of Functional Inhibition and Claimed ProfilesAlexey Koval, Cédric Boudou, Vladimir L Katanaev
Bioscience Reports|April 23, 2026
Small-molecule inhibitor of Gαo for GNAO1 encephalopathyYonika A Larasati, Alexey Koval, Vladimir L Katanaev
Pageof 7